Ars Pharmaceuticals, Inc. (SPRY)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

5

(1)

17

0

1

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
21-Aug-24 6:49 PM View:	20-Aug-24 Planned Option Sale ($200.00K)	Scott Kathleen D. Chief Financial Officer		Ars Pharmaceuticals, Inc. - SPRY	0% 13.2K	0	0	--	--	Show Txns Hide Txns

Yesterday 4:30 PM View:	19-Nov-24 Private Sale (Planned) Duplicate ($1.39M)	Lowenthal Richard E President and CEO Director 10% Owner		Ars Pharmaceuticals, Inc. - SPRY	(11%) 13.05M to 11.57M	0	0	--	--	Show Txns Hide Txns

Yesterday 4:30 PM View:	19-Nov-24 Private Sale (Planned) ($1.39M)	Tanimoto Sarina Chief Medical Officer 10% Owner		Ars Pharmaceuticals, Inc. - SPRY	(11%) 13.05M to 11.57M	0	0	--	--	Show Txns Hide Txns

19-Sep-24 4:30 PM View:	18-Sep-24 Planned Option Sale ($140.00K)	Karas Eric Chief Commercial Officer		Ars Pharmaceuticals, Inc. - SPRY	0% 5.69K	0	0	--	--	Show Txns Hide Txns

21-Aug-24 6:51 PM View:	20-Aug-24 Planned Option Sale ($750.00K)	Dorsey Brian Chief Operating Officer		Ars Pharmaceuticals, Inc. - SPRY	0% 6.02K	0	0	--	--	Show Txns Hide Txns

28-Aug-24 4:30 PM View:	26-Aug-24 Private Sale ($1.09M)	Thompson Peter A Director		Ars Pharmaceuticals, Inc. - SPRY	(10%) 9.24M to 8.29M	0	0	--	--	Show Txns Hide Txns

28-Aug-24 4:26 PM View:	26-Aug-24 Private Sale Duplicate ($1.09M)	Orbimed Advisors LLC Director		Ars Pharmaceuticals, Inc. - SPRY	(10%) 9.24M to 8.29M	0	0	--	--	Show Txns Hide Txns

27-Mar-24 7:37 PM View:	27-Mar-24 Purchase $4.95M	Ra Capital Management, LLC Director 10% Owner		Ars Pharmaceuticals, Inc. - SPRY	15% 9.46M to 10.86M	0	0	--	--	Show Txns Hide Txns

17-Jun-24 6:39 PM View:	13-Jun-24 Gift 0	Shah Pratik Director		Ars Pharmaceuticals, Inc. - SPRY	(52%) 10.16M to 4.82M	0	0	--	--	Show Txns Hide Txns